EICHORCondition: Rotator Cuff Tears · Rotator Cuff Injuries · Surgery · Sponsor: Brooke Army Medical Center
Interested? Contact the study team ↓
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
Rotator cuff (RC) injuries are particularly prevalent, difficult to repair, and attachment between the bone and tendon is notoriously difficult to achieve. The most common method and current standard of care (SOC) for reattaching connective tissues (e.g., ligaments, tendons) to bone typically involves suture anchor-based techniques, but this is fraught with problems. More specifically, re-tearing of the connective tissue after this procedure occurs in 30-60% of cases, and can be even higher in patients who engage in smoking, have a diagnosis of diabetes, etc. To address these clinical challenges, Sparta Biopharma Inc. (Sparta) developed a unique technology, called BioEnthesis, to improve the connection between the tendon and bone. Pre-clinical in vivo studies demonstrated that the biphasic bovine cancellous matrix regenerated at the bone-soft tissue interface-thereby leading to high structural integrity and will likely lead to reduced re-tear rates over time. The investigators hypothesize that patients in this interventional cohort will experience enhanced mobility, reduced pain, and less re-tears after RC procedures versus a standard suture anchor-based repair.
This description comes directly from the study's public registry record.
David J Tennent, MD · 210-916-2048 · David.J.Tennent.mil@health.mil
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * DEERS-eligible * Adults, between the ages of 18-65 (inclusive) * Presenting with a rotator cuff tear that is reparable surgically (a reparable tear is defined as tear of the RC where it is possible to bring the retracted tendon edge back to the greater tuberosity of the humerus under minimal tension) * Ability to undergo surgery to repair rotator cuff tear * Willingness to commit to study procedures including study intervention and a 12-month follow-up * Fluency in speaking, reading, comprehending English * 1-2 tendon full thickness reparable RC tear (full thickness tear is defined as a tear that involves the majority of supraspinatus and less than half of the infraspinatus under minimal tension, with no subscapularis involvement beyond the upper border) * Patients who have high-grade partial thickness tears where the surgeon elects to complete the tear during surgery before repairing the tendon(s) Exclusion Criteria: * Previous shoulder surgery (excluding acromioplasty or diagnostic arthroscopy) * Inability to receive an MRI * Current (within the past 6 months) tobacco user * Unwilling to remain tobacco free for the duration of the study * Current lower limb injuries requiring walking assist devices such as crutches and walkers * Diagnosed with systemic arthritis * Significant neck pathology * Active joint or systemic infection * Currently enrolled, or plans to enroll, in another clinical trial during this study (that would affect the patient's safety or results of this trial) * Significant muscle paralysis of the shoulder girdle * Currently pregnant or plans to become pregnant during this study * Inability of the surgeon to repair the tear with remaining defect no greater than 10 mm in diameter * Inability of the surgeon to repair the tear with less than 1cm of medialization * Evidence of other significant shoulder pathology (such as Grade III osteoarthritis) * Has a history of alcohol abuse, illicit drug use, significant mental illness, physical dependence to any opioid, or drug abuse or addiction * Major medical illness that would preclude undergoing surgery * Major psychiatric illness or developmental handicap * Goutallier III classification and above
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| 10th Medical Group - Air Force Academy | Air Force Academy, Colorado, United States | Recruiting |
| Walter Reed National Military Medical Center | Bethesda, Maryland, United States | Recruiting |
| University of North Carolina Chapel Hill | Chapel Hill, North Carolina, United States | Recruiting |
| Duke University | Durham, North Carolina, United States | Recruiting |
| Brooke Army Medical Center | San Antonio, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06289686